Article

Evaluation of COVID-19 vaccination strategies with a delayed second dose

2021-01-29

Abstract excerpt

Two of the COVID-19 vaccines currently approved in the United States require two doses, administered three to four weeks apart. Constraints in vaccine supply and distribution capacity, together with a deadly wave of COVID-19 from November 2020 to January 2021 and the emergence of highly contagious SARS-CoV-2 variants, sparked a policy debate on whether to vaccinate more individuals with the first dose of available...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b2b990f5-2d48-5af8-af11-a08edc7f82b9
DOI: 10.1101/2021.01.27.21250619

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of COVID-19 vaccination strategies with a delayed second doseDOI 10.1101/2021.01.27.21250619Read

Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity Read

Analysis of the Potential Efficacy and Timing of COVID-19 Vaccine on Morbidity and MortalitySemantic proximity Read

Waning of SARS-CoV-2 vaccine-induced immunity: A systematic review and secondary data analysisSemantic proximity Read

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and diseaseSemantic proximity Read

COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity Read

Critical assessment of the impact of vaccines and waning/boosting of immunity on the burden of COVID-19 in the U.SSemantic proximity Read

Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling studySemantic proximity Read

Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in FranceSemantic proximity Read

The Effectiveness of the First Dose of BNT162b2 Vaccine in Reducing SARS-CoV-2 Infection: Real-World EvidenceSemantic proximity Read

The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidenceSemantic proximity Read

COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulationSemantic proximity Read

Risk of COVID-19 after Natural Infection or VaccinationSemantic proximity Read